chr10-117241738-C-A

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_003054.6(SLC18A2):​c.45C>A​(p.Ser15Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000242 in 1,608,616 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00014 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000012 ( 0 hom. )

Consequence

SLC18A2
NM_003054.6 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 1.00

Publications

0 publications found
Variant links:
Genes affected
SLC18A2 (HGNC:10935): (solute carrier family 18 member A2) This gene encodes an transmembrane protein that functions as an ATP-dependent transporter of monoamines, such as dopamine, norepinephrine, serotonin, and histamine. This protein transports amine neurotransmitters into synaptic vesicles. Polymorphisms in this gene may be associated with schizophrenia, bipolar disorder, and other neurological/psychiatric ailments. [provided by RefSeq, Jun 2018]
SLC18A2-AS1 (HGNC:55843): (SLC18A2 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.06081128).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC18A2NM_003054.6 linkc.45C>A p.Ser15Arg missense_variant Exon 2 of 16 ENST00000644641.2 NP_003045.2 Q05940-1
SLC18A2-AS1NR_184310.1 linkn.159G>T non_coding_transcript_exon_variant Exon 2 of 3
SLC18A2-AS1NR_184309.1 linkn.113+147G>T intron_variant Intron 1 of 1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC18A2ENST00000644641.2 linkc.45C>A p.Ser15Arg missense_variant Exon 2 of 16 NM_003054.6 ENSP00000496339.1 Q05940-1

Frequencies

GnomAD3 genomes
AF:
0.000138
AC:
21
AN:
152016
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000383
AC:
9
AN:
234764
AF XY:
0.0000389
show subpopulations
Gnomad AFR exome
AF:
0.000410
Gnomad AMR exome
AF:
0.0000589
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000972
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000124
AC:
18
AN:
1456600
Hom.:
0
Cov.:
33
AF XY:
0.0000124
AC XY:
9
AN XY:
724348
show subpopulations
African (AFR)
AF:
0.000392
AC:
13
AN:
33184
American (AMR)
AF:
0.0000674
AC:
3
AN:
44502
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25972
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39376
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85706
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51936
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5392
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1110412
Other (OTH)
AF:
0.0000333
AC:
2
AN:
60120
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000138
AC:
21
AN:
152016
Hom.:
0
Cov.:
33
AF XY:
0.0000943
AC XY:
7
AN XY:
74234
show subpopulations
African (AFR)
AF:
0.000483
AC:
20
AN:
41384
American (AMR)
AF:
0.0000654
AC:
1
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5150
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4814
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10600
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
312
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67990
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000232
Hom.:
0
Bravo
AF:
0.000166
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000166
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Dec 01, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.45C>A (p.S15R) alteration is located in exon 2 (coding exon 1) of the SLC18A2 gene. This alteration results from a C to A substitution at nucleotide position 45, causing the serine (S) at amino acid position 15 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

not provided Uncertain:1
Jun 18, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces serine, which is neutral and polar, with arginine, which is basic and polar, at codon 15 of the SLC18A2 protein (p.Ser15Arg). This variant is present in population databases (rs371946127, gnomAD 0.05%). This variant has not been reported in the literature in individuals affected with SLC18A2-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The arginine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.22
BayesDel_addAF
Benign
-0.49
T
BayesDel_noAF
Benign
-0.58
CADD
Benign
19
DANN
Uncertain
0.98
DEOGEN2
Benign
0.17
T;T
Eigen
Benign
-0.44
Eigen_PC
Benign
-0.29
FATHMM_MKL
Benign
0.72
D
LIST_S2
Benign
0.68
.;T
M_CAP
Benign
0.010
T
MetaRNN
Benign
0.061
T;T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
1.7
L;L
PhyloP100
1.0
PrimateAI
Uncertain
0.49
T
PROVEAN
Benign
-1.4
N;.
REVEL
Benign
0.024
Sift
Benign
0.34
T;.
Sift4G
Benign
0.34
T;.
Polyphen
0.0
B;B
Vest4
0.31
MutPred
0.36
Gain of MoRF binding (P = 0.043);Gain of MoRF binding (P = 0.043);
MVP
0.043
MPC
0.41
ClinPred
0.039
T
GERP RS
2.3
Varity_R
0.15
gMVP
0.67
Mutation Taster
=82/18
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs371946127; hg19: chr10-119001249; API